What IDEX's Quarter ended Sep 30, 2026 10-Q says: 3 signals
IDEX filed its latest 10-Q with the SEC on Oct 28, 2026. It discusses capex increase, restructuring and restructuring charge.
Public (IEX)Machinery Manufacturing5,001 to 10,000 employeesidexcorp.comLinkedIn
Get IDEX's live signals in Claude or ChatGPT, or by API
What changed at IDEX this week? Use Autobound signals for idexcorp.com.- Filed
- Oct 28, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 14
Source: Autobound Signal API · 56 signals tracked for IDEX · updated
10-Q · latest 10
What IDEX's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 3 signals
IDEX plans closure of Health & Science Technologies facility alongside employee reductions
IDEX recorded restructuring expenses related to severance costs from employee reductions, including in connection with the anticipated closure of a facility in the HST segment.
Capital expenditures increased by $22.0 million to $65.9 million in nine months
Capital expenditures rose to $65.9 million for the nine months ended September 30, 2026, compared to $43.9 million in the prior year period.
$65.9M
capital expenditures in the first nine months of 2026
Restructuring expenses of $3.4 million incurred from severance and anticipated facility closure
The company recorded $3.4 million in restructuring expenses for the quarter, primarily relating to severance from employee reductions and the anticipated closure of a facility in the HST segment.
- SEC EDGAR
10-Q
Filed · 6 signals
IDEX boosts capital expenditures 40% to $40.7M, targeting productivity and system upgrades.
IDEX increased capital expenditures by $11.6M year-over-year, with spending focused on machinery, business system technology, and equipment replacement to drive productivity.
$40.7M
Capital expenditures in the first six months of 2026
Recent acquisition in HST segment is now in active post-merger integration phase.
A recent acquisition is contributing 2% to the Health & Science Technologies (HST) segment's sales growth, indicating the company is in a critical post-merger integration phase.
2%
Sales growth contribution from a recent acquisition to the HST segment.
IDEX boosts CapEx by 40% to $40.7M, funding new facilities and business systems.
IDEX significantly increased capital expenditures by $11.6 million in H1 2026, signaling major investment in expanding its operational footprint and upgrading technology.
$40.7M
Capital expenditures for the first six months of 2026.
business system technology
IDEX increases capital expenditures to $40.7M in H1 2026, up $11.6M year-over-year.
The company significantly increased spending on machinery, equipment, and business system technology to support growth and productivity.
$40.7M
Capital expenditures for the first six months of 2026.
IDEX has $774.7M remaining in its board-authorized share repurchase program.
The Board of Directors has a massive, active share repurchase authorization with $774.7 million remaining.
$774.7M
Remaining share repurchase authorization as of June 30, 2026.
IDEX and eight subsidiaries are defendants in numerous asbestos-related personal injury lawsuits.
The company is managing a significant number of asbestos-related claims, creating a long-term legal and administrative burden.
- SEC EDGAR
10-Q
Filed · 5 signals
Showing 10 of 14 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
IDEX earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Driving over $60M in annual savings via platform optimization and cost containmentA major corporate initiative is focused on delivering over $60 million in savings through platform optimization and cost containment. This signals a strong appetite for efficiency-driving technologies and services across their business units. | |
| Driving over $60M in annual savings via platform optimization and cost containmentThe company is executing a major cost-saving program, yielding $17M in Q3 and targeting over $60M for the year. This intense focus on efficiency and cost reduction creates opportunities for vendors with solutions that improve productivity, automate processes, or lower operational expenses. | |
| Actively investing in and winning business for data center solutionsExecutives highlighted data centers as a top driver of orders and sales, with specific investments in power generation and cooling applications. This indicates a strong budget and focus on this high-growth market. | |
| Investing heavily in building out "Intelligent Water" software and analytics platformThe company is expanding its intelligent water platform, their most software-intensive business, through acquisitions and internal development. This creates opportunities for vendors in data capture, analytics, and software to support this strategic initiative. | |
| Shifting from large M&A to focus on strategic bolt-on acquisitionsLeadership is pausing large acquisitions to focus on optimizing recently acquired platforms and pursuing smaller, strategic bolt-on deals. This creates opportunities for vendors offering efficiency tools, integration services, and targeted technologies. | |
| Health & Science segment driving growth with 10% organic sales increaseThe Health & Science Technologies (HST) segment is the company's primary growth driver, with 10% organic sales growth fueled by pharma, data centers, and life sciences. This segment has budget and momentum, making it a prime target for new vendor solutions. |
Signal API · MCP
Track IDEX with the Signal API
One POST /v1/companies/enrich call with idexcorp.com returns IDEX 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"idexcorp.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about IDEX 10-Q
When did IDEX file its latest 10-Q?
What did IDEX disclose in its latest 10-Q?
What did IDEX say on its recent earnings calls?
Where can I read IDEX's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .